Online tool tracks COVID-19 vaccine development

By The Science Advisory Board staff writers

May 28, 2020 -- A new interactive online tool to track the progress of coronavirus vaccine candidates currently under development has been published by the University of Notre Dame Center for Research Computing.

The tracker lists key scientific information about the different vaccine candidates including immunogenicity, manufacturing, and stability factors. The information listed in the interactive charts includes development platform or targeted proteins, vaccine delivery system, and delivery route.

Vaccine Mapper
New Vaccine Mapper tracks the progress of coronavirus vaccine candidates. Image courtesy of University of Notre Dame Center for Research Computing.

The Vaccine Mapper uses public information on coronavirus vaccines pulled from resources including the World Health Organization, the Milken Institute, and the global coronavirus cases map from Johns Hopkins University.


Copyright © 2020 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here